Cure of experimental <i>Trypanosoma vivax</i> infection with a single dose of an unmodified antibody-based drug targeting the invariant flagellum cell surface protein IFX

Delphine Autheman(Hull York Medical School), Gavin J. Wright(University of York), Katherine Harcourt(Wellcome Sanger Institute), Cordelia Brandt(Wellcome Sanger Institute), Cristina Viola(University of York), Simon Clare(University of Cambridge)
bioRxiv (Cold Spring Harbor Laboratory)
July 8, 2025
Cited by 0


Related Papers